Funding for this research was provided by:
National Major Science and Technology Projects of China (2018ZX09301021-005)
Received: 24 August 2019
Accepted: 18 October 2019
First Online: 26 October 2019
Ethics approval and consent to participate
: Our study complied with the standards of the Declaration of Helsinki. Ethical approval was obtained from the Sun Yat-sen University Cancer Center research ethics committee. Written informed consent was obtained from all subjects.
: Not applicable.
: Dajun Yang, Douglas D. Fang, Guangfeng Wang, Saijie Zhu, Qiuqiong Tang, Ping Min, Miaoyi Wu, Chunyang Tang, and Fei Zhang are currently the full-time employees of Ascentage Pharma and own the stock of the company. Yifan Zhai is currently full-time employee of HealthQuest Pharma Inc. All the authors declare that they have no competing interests.